Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.997
-6.82 %
$ 3.33 M
Market Cap
-0.28
P/E
BALANCE SHEET
5.95 M
ASSETS
1.9 M
LIABILITIES
4.06 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Shuttle Pharmaceuticals Holdings, Inc.
| Current Assets | 5.59 M |
| Cash & Short-Term Investments | 5.46 M |
| Receivables | 14.9 K |
| Other Current Assets | 114 K |
| Non-Current Assets | 359 K |
| Long-Term Investments | 0 |
| PP&E | 359 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 1.04 M |
| Accounts Payable | 283 K |
| Short-Term Debt | 701 K |
| Other Current Liabilities | 58 K |
| Non-Current Liabilities | 854 K |
| Long-Term Debt | 439 K |
| Other Non-Current Liabilities | 415 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 2.6 | 8.4 | 0.5 | 0.1 | 0.4 | 50.7 K |
| Short Term Investments | 2.9 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14.9 K | 0 | 0 | 0.2 | 3.82 K | 49.2 K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0.1 | 0.2 | 4.87 K | 12.6 K | 0.3 | 2.54 K |
| Total Current Assets | 5.6 | 8.6 | 0.5 | 0.3 | 0.6 | 0.1 |
| PP&E | 0.4 | 68.7 K | 0.1 | 0.2 | 838 | 18.8 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 6.48 K | 6.48 K | 6.48 K | 6.48 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 6.0 | 8.7 | 0.7 | 0.5 | 0.6 | 0.1 |
| LIABILITIES | ||||||
| Accounts Payable | 0.3 | 0.1 | 0.8 | 0.5 | 30.7 K | 79.1 K |
| Short Term Debt | 0.7 | 0.8 | 0.9 | 0.7 | 0.4 | 0.3 |
| Other Current Liabilities | 58 K | 35.3 K | 0.5 | 0.9 | 0.1 | 12.2 K |
| Total Current Liabilities | 1.0 | 1.0 | 2.2 | 2.1 | 0.6 | 0.4 |
| Long Term Debt | 0.4 | 0 | 62.4 K | 0.1 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.9 | 1.0 | 2.3 | 2.2 | 0.6 | 0.4 |
| EQUITY | ||||||
| Common Stock | 20 | 136 | 93 | 93 | 179 | 0.5 |
| Retained Earnings | (25.4) | (8.9) | (5.8) | (4.5) | (1.9) | (1.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 16.3 K | 16.3 K | 16.3 K | 0 |
| Total Equity | 4.1 | 7.7 | (1.6) | (1.7) | 27.5 K | (0.3) |
| Total Liabilities and Equity | 6.0 | 8.7 | 0.7 | 0.5 | 0.6 | 0.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 15.9 | 10.4 | 13.6 | 13.6 | 13.6 | 13.6 |